DatasetName,CAPZA1_S(106) CAPZA1_S(9),CAPZA1_T(63)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,0.43894733286938015,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5621866835631559,
SR2019_LM2_Biol_repl_1,0.493625273520661,
RCJD2014_15min_1,0.5227723160901878,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5138583882307076,
RKK2015_TNF-α/basal,0.4885722307822993,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.49052574074948296,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,0.4915610647256977,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.49432370036960394,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,0.5440009190344918,
HS2024_7_B_N1,,0.6598379408001955
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,0.5219524311911793,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.4294222079132097
WZ2023_Pu_010_30min,0.5091988378494005,
AS2011_Ratio H/L Proteins RNAi_2,0.499542961907963,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5539253187300582,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.46329891002194684,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5201984106579811,
JJ2018_Ratio H/L normalized___1,0.5142417061690717,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.43742636430008597,
AH2018_SILAC_MR_2_N,0.5700997551345648,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.4598034826042291,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.4563935019952236
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.4415588454676963,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.48805403699070227,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5077938769834578,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.4943512409878881,
WZ2023_Pu_005_10min,0.5052668932436748,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5136872076350505,
AH2018_SILAC_MR_2_X,0.561904806585682,
HS2024_4_PD_T2,,0.5747584281865957
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5331091500834143,
FR2021_Norm.Intensity.B,0.42055164360055264,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5135972963417424,
JJ2018_Ratio M/L normalized pP3,0.5185008299409566,
AH2018_SILAC_M_2_N,0.4948334313810281,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.539979942495539,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5067151082702037,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5070680001939408,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,0.542002808588393,
AH2018_SILAC_2_X,0.48998634934991125,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5548691960634196,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.5071647690777883,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5160529787445122,
CW2012_10 µM Gef/control Experiment 2 Replicate B,0.43752497424804127,
HS2024_7_B_T3,,0.4781231414976382
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5508095077158434,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.5311425143923909,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,0.47585939356141227,
RCJD2014_20min_mean,0.46136974573006395,
FR2021_Norm.Intensity.H,0.4041327813825208,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.6589005430341014
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.4714780735686288,
PG2020_Intensity Mock_10h_D,0.514641718910804,
SR2019_MCF10A_Biol_repl_2,0.4724476177861114,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.5753035738253484,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.4762094412921204
RCJD2014_5min_1,0.5222571064939698,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.5050984912892595,
CR2017_Ratio Replicate 3.3,0.5193344903838947,
PG2020_Intensity 2h_C,0.5014448249051046,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.48149837215485536,
KBE2022_Log2_Ex_8_T,0.46334149465777097,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,0.6775106348695129
AH2018_LFQ_M_2_C,0.5672453706790219,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.654620326264657
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.48591102726451907,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.49157965584240104,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5030333868895668,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5853677167025388,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),0.4024799326145502,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.4154705376296444,
HS2024_8_I_T3,,0.5358178175436231
CF2017_EOC 3,0.4909106897762656,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.510002475893411,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.489266068686516,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5221724173538982,
FSO2013_Ratio H/M normalized Rep2,,0.4297331378197572
RAM2015_Log2 A,,
HS2024_8_PD_T1,,0.6288725774737703
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.49275206288067963,
KS2014_Intensity E15_2,0.548822353573488,
BS2014_Log2(Ratio H/L protein),0.4319174801273238,
PG2020_Intensity 8h_A,0.476613484705916,
HS2024_7_I_T1,,0.4676883925516576
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.6232228553101712,
SR2019_JIMT1_Biol_repl_1,0.43314663661782316,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5145420598372925,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5029934968006073,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5582011990085427,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.43217775646883
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.4947361208728853,
CW2012_10 µM Gef/control Experiment 1 Replicate A,0.5684175444254843,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,0.4291156084736538,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.470007996951979,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.49836560085567627,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,0.48453303191156727,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.4950091751555076,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5639586741563631,
DL2023_control-1,,
AR2021_ALG 10 μM,0.4781905511132343,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.48603172535890116,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5059313329532418,
JW2021_After_3,,
GF2025_P8_Sph,0.5186408226117705,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.49248020017233796,
CK2022_11 200-1,0.47287430381966267,
CK2022_12 200-1,0.44538810525911493,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5067616599816864,
AH2018_TMTMS2_2_N,0.5274840926948574,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.48945825146155086,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.47718249107980815,
KS2014_Intensity N4,0.5470735286744403,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.4905042450703493,
CK2022_14 200-1,0.4405948064821479,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.46818924032685105,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5056020789043421,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,0.4885548943371999,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5080455229875669,
CF2017_EOC 1,0.48597488627968344,
CK2022_3 200-1,0.47417949619154043,
AH2018_LFQ_IT_3_C,0.4858255705031602,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.4525612368657682,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.6058136537803497,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,0.5461504061096858
CW2012_10 µM Gef/control Experiment 2 Replicate A,0.4634550258566571,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.4967772750524224,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.47214469749733584,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.47482620258495256,
HS2024_4_B_T1,,0.5180389106800148
MV2014_Ratio M/H normalized A3___1 (10 min),0.4950914027475176,
SR2019_BT549_Biol_repl_4,0.46175215287637106,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.2758760694493699,
CR2017_Ratio Replicate 3.2,0.46795206214531143,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.47487238931321585,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,0.48746970441050486,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.44122131926672037,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4748643590068546,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),0.43431365026864244,
WZ2023_Su_005_10min,0.5069560781607437,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),0.4912480374428292,
KBE2022_Log2_Ex_41_T,0.5192609637010969,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.48976476322854645,
HS2024_5_PD_T3,,0.5367450343399353
AH2018_TMTMS3_3_X,0.4868350221788831,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.47041885183337007,
AH2018_LFQ_M_1_N,0.5677605491395683,
KBE2022_Log2_Ex_27_U,0.49915214111776673,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5556649208462159,
AH2018_SILAC_M_1_N,0.5231930583726783,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5097288641318377,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.504347196416228,
SR2019_SKBR3_Biol_repl_3,0.5209457844254143,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.4209026994761164
CW2012_10 µM Erl/control Experiment 2 Replicate B,0.5196753194393585,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.4470923315429339
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,0.5043757408865639,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.4708846939221936,
AH2018_TMTMS2_3_X,0.5223911250997011,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,0.4174317792558504,
AH2018_TMTMS2_1_C,0.5249040788029959,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,0.46893278635973046,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5127434353937027,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,0.4448647879019416
AH2018_LFQ_1_X,0.5429187518702515,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5587200256159349,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5522947724391777,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,0.4302865319471819,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.6623247748387188
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.4734363533084339
SR2019_LM2_Biol_repl_3,0.49422466529076625,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.49368754083232125,
CW2012_10 µM Erl/control Experiment 2 Replicate A,0.40398136774535276,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.48826495746759857,0.7021881239387816
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.508279134484353,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.4786945842550484,
KBE2022_Log2_Ex_9_U,0.45542422082036105,
AH2018_SILAC_M_3_N,0.5043858986744891,
KBE2022_Log2_Ex_13_T,0.47259816974730107,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.5300217751564327,
PG2020_Intensity Mock_10h_C,0.4912529691422053,
CF2017_OSE 29,0.49210605316418576,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,0.5499080756074285
PG2020_Intensity 10h_A,0.4865894409365442,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5094633188286576,
SAS2015_PLX/AZD_Exp1,0.45511301073744537,
FR2021_Norm.Intensity.A,0.4496573278190419,
FSO2013_Ratio H/M normalized Rep1___1,,0.7214170985726963
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.4731438778983632,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.4969383454228449,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4754440410953845,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5729917376745048,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.5804732137003914
CK2022_7 200-1,0.4701876089827056,
CK2022_5 200-1,0.47448700079192824,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5575254389116956,
AH2018_SILAC_MR_1_X,0.5617170273327629,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.4832573632160645,
AH2018_SILAC_3_C,0.5094817533942295,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.7187432596042186
CK2022_4 16-1,,
AS2011_Ratio H/L,0.44018999511174217,
SR2019_MCF7_Biol_repl_4,0.4272992600188696,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.559131393865331,
SAS2015_PLX/DMSO_Exp1,0.5172400010202992,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.4704334306794149,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5018797819346528,
JJ2018_Ratio M/L normalized,0.5389258849485903,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.4816924716835286,
AH2018_SILAC_IT_2_N,0.5291655641293839,
AH2018_SILAC_IT_1_X,0.46463338616036265,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.4520677100944603,
WZ2023_Pe_025_20min,0.5064683576071861,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.49531741520562034,
AH2018_LFQ_2_N,0.5509062626285771,
HS2024_4_I_N2,,0.579369176511347
AH2018_TMTMS2_3_N,0.5239037135058882,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.6460178326224616
WZ2023_Su_005_30min,0.5108238017216233,
SR2019_HCC1419_Biol_repl_4,0.48728550266151616,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.47158379274752726,
AS2011_Ratio H/L Protein,0.4291156084736538,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6474036895147333,
WZ2023_Su_025_10min,0.5081188151819357,
AH2018_LFQ_IT_4_X,0.5135980890496664,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.508446347122392,
CW2012_10 µM Gef/control Experiment 1 Replicate B,0.4805258433274985,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,0.4352021375099401,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.4697703761711773
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.48732488067391205,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.48823311284562354,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,,0.6710996840763126
RN2012_L10,,
PG2020_Intensity 4h_C,0.4853847110483236,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.48645519173689733,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.46794616615139917,
HS2024_4_B_T3,,0.5877563428191717
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.5079470996846883
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.5803669084242057
KBE2022_Log2_Ex_6_U,0.48845439163301074,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5133198738937492,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.43630429894881523,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,0.4917977572268153,
CK2022_6 200-1,0.471335811039338,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.4713799118027908,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.4884471689022192,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,0.45788564442129387,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.7068724317901123
SAS2015_AZD/DMSO_Exp1,0.5579672948123576,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,0.5216213501639987
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.48792382386438116,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5004116607101352,
EP2017_Untreated R#3 normalized log2 ratio,,0.5810103896065305
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.4689952271226564,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4962656103485509,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5246668388117867,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.4136914986630058
AS2011_Ratio H/L Normalized by Protein (Unnormalized),0.49620298643254435,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.48595780472066885,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),0.5333759847324527,
HS2024_7_I_N1,,0.3978744599314597
KBE2022_Log2_Ex_29_T,0.4658677780439269,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,0.5043757408865639,
CW2012_10 µM Gef/control Experiment 3 Replicate B,0.6174732671519427,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,0.5701522603657978,
SAS2015_PLX/DMSO_Exp2,0.5433872940373413,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5682133029847607,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5377155307023759,
PG2020_Intensity CT_C,0.503501364571819,
ZCP2016_Ratio H/L Rep 1,0.5854615223283642,0.6754346429533814
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.49331851324004117,
EP2017_Untreated R#3 log2 ratio,,0.5864795614974946
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,0.4849435594546546,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4887607539839851,
HS2024_8_PD_T2,,0.5323494452440062
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.5879301259535599
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.44963846590486034,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.45055191400265626,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5488971938625278,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),0.4780494739650044,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.6100278949602687
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5616593040631752,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4685451338283665,
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.4784213199023408,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.6509185808795824
PG2020_Intensity Mock_10h_B,0.5177822896997376,
WZ2023_Su_025_30min,0.5052218730266776,
AH2018_LFQ_4_N,0.558792870186738,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,0.48499630937781735,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.6106896418067496
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.5172671633127877,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.4467536612531453,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,0.48764590630361504,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,0.45076069242025596,
HS2024_5_I_T2,,0.5995509241424747
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),0.5062424961928149,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4763889662637164,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.6038653404406229,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,0.5321121746361052,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5281817851140483,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.6499097753060464
SR2019_BT549_Biol_repl_1,0.48218725943367735,
AH2018_LFQ_M_4_N,0.5687694984487877,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.4697183314481805,
AH2018_LFQ_2_X,0.5561507717839993,
PG2020_Intensity 2h_B,0.5086140555666653,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4856432858000118,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5138425416569448,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,0.490405626510114,
AH2018_SILAC_IT_1_N,0.49039812415052375,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5390342692294673,
CR2017_Ratio Replicate 2.4,0.4938730478233305,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5558708634108025,
RKK2015_TNF-α/IKKb,0.38566149299035885,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5058338416087724,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.49516543937600677,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5033160986258715,
SR2019_BT549_Biol_repl_2,0.4891654628774328,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5138860312769159,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.5625311788131063
WZ2023_Su_025_20min,0.5048804700918876,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.5634050416117312,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.4955062060098884,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,0.48499630937781735,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,,0.4640813808591552
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5129662225290066,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5656411309873135,
AH2018_LFQ_M_4_C,0.5746450169397447,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.46899543252248643,
LY2019_P3-,,
FR2021_Intensity.A,0.44217393982486675,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5102873421983998,
HS2024_8_PD_T3,,0.5954361136854375
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4984489586171895,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5137821781215914,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.509729450873349,
GF2025_P10_Adh,0.543157656302279,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.4951419396925396,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,0.5928236408257238
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5241074561489784,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.48194390931866826,
HS2024_8_I_N2,,0.5452864617473434
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5192055137825954,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.47525842564719384,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5685434150367003,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5121733762566348,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.4913361932869986,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.5158836191577806,
JJ2018_Ratio H/L normalized pP3___1,0.4952585341589564,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5124931938102412,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5244368248548437,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.48731478690455055,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,0.4705517317226943,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.49535054406416934,
HS2024_5_B_T2,,0.4763999404736698
HS2024_6_I_T1,,
HS2024_5_B_T3,,0.5742034949882903
JJ2018_Ratio H/M normalized pP1___1,0.46115923953475824,
KBE2022_Log2_Ex_36_U,0.5208309345387353,
AH2018_TMTMS3_3_N,0.4733485172778409,
SR2019_HCC1419_Biol_repl_2,0.4804213037997005,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5521361535665377,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,0.516980973582332,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5044139775220066,
KS2014_Intensity C2,0.47057093626499247,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5008491694551429,
CK2022_9 200-1,0.46909504580928185,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.47467899788054924,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.4638385235779918
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,0.5301696358371746,
RKK2015_TNF-α/TNF-α+SC-514,0.37864684564341955,
CR2017_Ratio Replicate 2.5,0.5318958827755798,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5319984731578906,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.49412529979882724,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.676312301543081
RKK2015_SC-514/basal,0.5228343668861247,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5116999193259089,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5149553795772304,
HS2024_5_I_T3,,0.5877968794290845
KS2014_Intensity N1,0.4990808716028994,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5837091967985757,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.4788449708681869,
AH2018_SILAC_MR_2_C,0.5517061412292849,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5026690903796373,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5642325765365465,
JJ2018_Ratio H/M normalized___1,0.4611567884362756,
RCJD2014_15min_2,0.6298066566808179,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,0.4496773557615666,
RN2012_H03,,
HS2024_5_B_N2,,0.5180111253627026
HS2024_5_I_N1,,0.5016320559114259
HS2024_6_I_N1,,
AR2021_KD 48h,0.47653637310806524,0.7925906722781335
FR2021_Intensity.B,0.4203258688897055,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,0.6816546396909156
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.5052610299806266,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.48256906001173805,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5109274721864286,
KBE2022_Log2_Ex_29_U,0.46407735324773847,
HS2024_7_B_T1,,0.4045935332757378
AH2018_LFQ_M_2_X,0.5673919962495316,
AH2018_LFQ_IT_4_N,0.5030119179971367,
CK2022_15 200-1,0.4350661239994091,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.46154021379092647,
JJ2018_Ratio M/L normalized pP3___1,0.5184725514243838,
KBE2022_Log2_Ex_34_T,0.49223952535723603,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.46870070600653,
AS2011_Ratio H/L Protein RNAi_2,0.5003597792626094,
MV2014_Ratio L/H normalized A3___1 (2 min),0.4763420708086693,
WZ2023_Su_010_30min,0.5072745412288816,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.4645368165595064
HS2024_8_B_T3,,0.3810941809855531
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.4830471597000553,
WZ2023_Pe_010_20min,0.5111141496141827,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.48347066086254353,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.4245489220210079,
KS2014_Intensity C1,0.4871386181207812,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.5107628227055963,
RKK2015_TNF-α+IKKb/TNF-α,0.638417147588852,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.4881097463065228,
AH2018_SILAC_M_2_X,0.487385669995984,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.4707981853666532,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5064915515209996,
PG2020_Intensity 6h_C,0.47338012795849305,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.5122890907043658,
JJ2018_Ratio M/L normalized pP1___1,0.5380002386928477,
AH2018_LFQ_M_3_N,0.5666048194809709,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5257742433989795,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5432319713054429,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5031332030627486,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),0.514755997400225,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5100383945007991,
AR2021_L41 10 μM,0.4020258351645243,
CF2017_EOC 2,0.48651993919235637,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.522108796866106,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,0.48317245757373106,
BS2014_Log2(Ratio H/L normalized Rep_3),0.4804746389315654,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.523542885218045,
AR2021_L41 1 μM,0.45467384046921877,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5260002388793285,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.4696147003379659,
ZX2022_Control Replicate 3,0.48670270867714427,
KS2014_Intensity C4,0.5793571232496854,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.4520387639741187,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5298048013703255,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,0.4612726567925951,
HS2024_7_B_T2,,0.4739960648800811
SAS2015_PLX/DMSO_Exp3,0.45307196949506223,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5620702629091017,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5261749615798005,
WZ2023_Pu_025_10min,0.5107392055439722,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,0.47601754793419637,
RCJD2014_10min_3,0.4324647864687686,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,0.45758593035862644,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.4627126543555303,0.5586239806185104
CF2017_EOC 4,0.4836118217595572,
JJ2018_Ratio H/L normalized pP1___1,0.51270363312521,
WZ2023_Pe_010_30min,0.5077097639198257,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.4921887034994905,
KS2014_Intensity C6,0.4751090872031223,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.4941184173992259,
JJ2018_Ratio H/M normalized pP1,0.4606585708983373,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5044808294398477,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5536322522950415,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.4994529645291391,
CR2017_Ratio Replicate 2.2,0.5054557949692087,
VOI2024_0.1uM 2 h_1 mono,0.43031117155899934,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.47682001745553015,
PG2020_Intensity CT_B,0.5039921919108582,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5756897203299498,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.3950495616098775,
AH2018_LFQ_3_C,0.5506781895988819,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5640351663621399,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.4802433962340252,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5393901625674435,
FR2021_Intensity.H,0.4041327813825208,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.520690896385443,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,0.6272369538696452
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.4896940190773214
AH2018_TMTMS2_1_X,0.5234035954986177,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.39209625422598643,0.5823998123060956
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.46549579256477963,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.42244191587957425,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5217386019434352,
HS2024_4_I_T3,,0.5362670335694222
AH2018_SILAC_1_X,0.5158319035114839,
PG2020_Intensity 10h_B,0.4920982409612982,
AH2018_TMTMS3_1_X,0.47548458568336915,
CF2017_FTE 14,0.5101513654383332,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5967927899224914,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.46633601012158854,
SR2019_HCC1419_Biol_repl_3,0.47288600413475546,
KBE2022_Log2_Ex_14_T,0.4828334380049516,
EP2017_Untreated R#2 normalized log2 ratio,,0.4702910218873632
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,,0.4926368692968773
SAS2015_PLX/AZD_Exp3,0.43390807307039125,
EP2017_Pervanadate R#2 log2 ratio,,0.4196785962089479
AS2011_Ratio H/L Normalized RNAi_2_1,0.490405626510114,
